The activation of the endocannabinoid system potentially contributes to hyperphagia, decreased energy expenditure, obesity and metabolic syndrome through the involvement of appetite modulators such as melanin-concentrating hormone (MCH), leptin and glucocorticoids within the hypothalamus [51,52]. This evidence concerns the gene PMCH and metabolic syndrome.